fda stops semaglutide Gives Ozempic New Side Effect Warning Hims & Hers stock falls
Description
One to watch

Celebrities aren't the only ones achieving success with GLP-1 weight loss medications

Maintaining normal glucose homeostasis is essential for a cell's survival and function

Kailera will launch a global Phase 2 study of ribupatide this year, while Hengrui will push the asset into Phase 3 in China.
The pharmaceutical manufacturers of semaglutide and tirzepatide initiated litigation to stop the production of compounded versions of these medications, and those lawsuits were recently dismissed

PlexusDx explains how these medications interact and when it's safe to use them together during your weight loss journey
